ArticleWorld journal of surgical oncology2026
Spread through air spaces as an independent prognostic factor in resected lung adenocarcinoma: the role of resection type.
Article in World journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSpread through air spaces (STAS) has emerged as an independent prognostic factor in lung adenocarcinoma, yet its interaction with resection type remains poorly defined. We aimed to evaluate the prognostic impact of STAS on overall survival (OS) and disease-free survival (DFS) according to resection type in surgically resected lung adenocarcinoma.
methodsWe retrospectively analysed 252 patients who underwent resection for lung adenocarcinoma at a single institution between 2016 and 2023. Patients were stratified into four groups by STAS status and resection type. Overall survival and DFS were estimated using Kaplan-Meier analysis with log-rank testing. Multivariable Cox regression was performed to identify independent prognostic factors.
resultsSTAS was present in 148 patients (58.7%). Among the four groups, patients who underwent STAS-positive sublobar resection demonstrated the worst prognosis, with a mortality rate of 50.0%, a median OS of 98 months, and a 5-year OS of 51.3%. STAS-positive lobar resection patients achieved a 5-year OS of 70.1%, comparable to STAS-negative lobar patients (67.8%). On multivariable Cox regression, STAS-positive sublobar resection was an independent predictor of mortality (HR 2.29, 95% CI 1.10-4.75; p = 0.026), as were lymphovascular invasion (HR 2.28; p = 0.001) and visceral pleural invasion (HR 2.14; p = 0.020). No significant difference in DFS was observed across groups (p = 0.963), suggesting that STAS primarily influences prognosis through its impact on overall survival rather than recurrence.
conclusionsSTAS positivity combined with sublobar resection independently predicts poor overall survival in lung adenocarcinoma. STAS status should inform surgical decision-making when sublobar resection is considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.